LOS ANGELES, Jun 13, 2005 (BUSINESS WIRE) -- Herbalife Ltd. (HLF) announced the appointment of Marion Flechtner-Mors, Ph.D., to its Medical Advisory Board.
Herbalife's Medical Advisory Board (MAB) is chaired by David Heber, M.D., director of the Center for Human Nutrition at the University of California, Los Angeles (UCLA). The MAB guides product research and development, ensuring the quality, benefits and safety of products. Members educate distributors on product usage and give health-news updates through multiple company channels and live training events around the world. The MAB also provides an educational resource for doctors and healthcare professionals, who recommend Herbalife products to their patients.
Flechtner-Mors is currently head of the Clinical Nutrition Research Unit and Obesity Research Group in the department of gastroenterology, endocrinology, nutrition and metabolism at the University of Ulm, Germany. She specializes in healthy nutrition and the relationship between obesity and associated metabolic disorders. Flechtner-Mors has undertaken substantial experimental research focusing on this subject, specifically the alleviation of obesity through energy-restricted diets, low-calorie diets, meal replacements and medication. Her work is dedicated to developing and evaluating long-term weight-loss programs and preventative strategies for nutrition-related disorders.
Flechtner-Mors is a graduate of the University of Ulm, where she gained a Ph.D. in human biology. Previous to this, she studied mathematics and chemistry at the University of Ulm. She also studied nutrition and gained a diploma degree at the University of Hohenheim.
Flechtner-Mors began her career as a laboratory technician at the Fa. Reinz, Neu Ulm and later in the biochemistry department at Ulm. She went on to become a researcher in the department of medicine before gaining more valuable experience at UCLA School of Medicine in Los Angeles. Since 1999, she has also worked as a senior researcher in nutrition at the University of Hohenheim Institute of Biological Chemistry and Nutrition. Over the last 13 years, Flechtner-Mors has been widely published around the world, based on her research.
Members of Herbalife's Medical Advisory Board include Luigi Gratton, M.D., vice president of the company's medical affairs and education; Mario Rosenberg, M.D., chief of gastroenterology at Cedars Sinai Hospital in Los Angles; Nataniel Viuniski, M.D., pediatrician in Brazil; and Yoshio Yoshimoto, M.D., and Ryuzaburo Tanino, M.D., of Japan.
Herbalife is a global network marketing company that sells weight management, nutritional supplement and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 60 countries through a network of more than one million independent distributors. The company celebrated its 25th anniversary with a gala celebration in Atlanta in April 2005. More information is available at www.herbalife.com